Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial

NCT07120776 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Hypertrophic Obstructive Cardiomyopathy \(HOCM\)
Left Ventricular Outflow Tract Obstruction
Myocardial Ischaemia

Interventions

DRUG: Camzyos (Mavacamten)

Sponsor

University of Manchester